Liquid biopsy proteomics of uveal melanoma reveals biomarkers associated with metastatic risk

Mol Cancer. 2021 Feb 24;20(1):39. doi: 10.1186/s12943-021-01336-4.

Gabriel Velez^{1

2

3}, Huy V Nguyen², Teja Chemudupati^{1

2}, Cassie A Ludwig², Marcus Toral^{1

2

3}, Sunil Reddy⁴, Prithvi Mruthyunjaya², Vinit B Mahajan^{5

6

7}

¹ Molecular Surgery Laboratory, Stanford University, Palo Alto, CA, USA.
² Department of Ophthalmology, Byers Eye Institute, Stanford University, Palo Alto, CA, 94304, USA.
³ Medical Scientist Training Program, University of Iowa, Iowa City, IA, USA.
⁴ Division of Oncology, Department of Medicine, Stanford University, Palo Alto, CA, USA.
⁵ Molecular Surgery Laboratory, Stanford University, Palo Alto, CA, USA. [email protected].
⁶ Department of Ophthalmology, Byers Eye Institute, Stanford University, Palo Alto, CA, 94304, USA. [email protected].
⁷ Veterans Affairs Palo Alto Health Care System, Palo Alto, CA, USA. [email protected].

No abstract available

Keywords: Biomarker; Cancer; HGFR; Liquid biopsy; Proteomics; SCFR; STAT3; Uveal melanoma; Vitreous.

Publication types